Community-based CAR T-cell therapy expands access to innovative cancer treatments, improving patient outcomes and reducing hospital stays for patients with blood cancers.
Gary L. Simmons, DO, MSHA
Advertisement
Articles by Gary L. Simmons, DO, MSHA
Advertisement
Latest Updated Articles
Bringing CAR T-Cell Therapies to Community Oncology PracticesPublished: November 4th 2025 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Daratumumab for Smoldering Multiple Myeloma
2
FDA Grants Orphan Drug Status to Novel CD33-Directed Immunotherapy for AML
3
Domvanalimab Combo Shows Enriched First-Line Efficacy in Advanced GI Cancers
4
Talquetamab Combo Yields High Responses in Heavily Pretreated Myeloma
5
